Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

Burns Clinical Trial

Official title:

HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00796627
• Other study ID #: NA_00018037
• Status: Terminated
• Phase: N/A
• First received: November 21, 2008
• Last updated: August 31, 2017
• Start date: December 2006
• Est. completion date: April 2014

Study information

• Verified date: August 2017
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research is being done to increase knowledge about wound healing and different factors that may affect healing in burn patients.

Description:

Burn injuries represent a major public health problem, requiring medical attention for more than one million Americans annually. Despite therapeutic advances, non-healing burn wounds and excessive scarring still result in significant long term physical and psychosocial morbidity. In this study we propose to perform clinical and research to study the role of circulating angiogenic cells (CAC) in promoting burn wound healing.

CAC's have been shown to contribute to vascularization and tissue repair in a number of animal models of tissue injury ischemia and mobilization of CACs into the peripheral blood has been demonstrated in burn wound patients.

We hypothesize that primary healing of burn wounds is dependent on repair of damaged vasculature, and that bone marrow derived stem cells, circulating angiogenic cells (CAC), play a critical role in the healing process. Furthermore we propose that the transcription factor Hypoxia Inducible Factor 1 alpha (HIF 1 alpha) through production of peptide products of its downstream target genes directs the "homing" of CAC's to the wound where they participate in healing events. The first aim of this study is to correlate mobilization of CAC's into the blood stream with the success of burn wound healing.

CAC's have been shown to contribute to vascularization and tissue repair in a number of studies. The relationship between mobilization of CAC's and burn wound healing has not been examined. In addition to surveying CAC numbers in the peripheral blood, we will assay levels of the putative mediators of CAC mobilization: Vascular Endothelial Growth Factor (VEGF), Placenta Growth Factor (PLGF), and Stromal Cell-Derived Factor (SDF-1). We hypothesize that individuals who are able to mount a large and sustained mobilization of CAC's into the peripheral blood from the bone marrow, will be more likely to heal the injured vasculature and go on to primary healing. Individuals with an inadequate mobilization of CAC's will fail to repair the damaged vasculature in the wound and proceed to necrosis and "conversion" to third degree, necrotic burn wounds.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 41
• Est. completion date: April 2014
• Est. primary completion date: April 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 14 Years to 75 Years

Eligibility

Inclusion Criteria:

Recruitment of patients at the Johns Hopkins Regional Burn Center for study will be based upon the following clinical criteria:

• Second degree scald burn of 10 cm2

• Age between 14 to 75 years

• Burn area equal or less than 95% of Burn Surface Area (BSA)

• Body temperature between 98.5 and 101 degree F

• Informed consent for enrolment into study

• Spanish speaking patients will be included when we have a Spanish consent form available.

Exclusion Criteria:

• First and third degree burn wounds

• Hemodynamic instability (SBP below 100, Heart Rate (HR) over 100, urine output less than 30 ml/hour

• Area of burn over 20% of BSA

• Hypothermia T<98.5 or Hyperthermia T>101 degree F

• Urine output less than 30 ml/hour

• Serum albumin less than 3 mg/ml.

• Subjects weighing less than 50 kg.

Related Conditions & MeSH terms

• Burns
• Wound Healing
• Wounds and Injuries

Intervention

Genetic:
• Healthy volunteers
Comparison of healthy volunteers to burn wounded volunteers

Other:
• Burn volunteers
Comparison of burn wounded volunteers to healthy volunteers

Locations

Country	Name	City	State
United States	Johns Hopkins Bayview Medical Center	Baltimore	Maryland

Sponsors (3)

Lead Sponsor	Collaborator
Johns Hopkins University	National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The Quantification of Circulating Angiogenic Cells in the Blood of Individuals Who Are Healthy Volunteers Compared to Those in Individuals Who Have Sustained a Burn Injury	Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.	baseline
Primary	Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury	Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.	0 to 24 hours post-operative
Primary	Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury	Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.	49 to 72 hours post-operative
Primary	Mean of Circulating Angiogenic Cells in the Blood of Individuals Who Have Sustained a Burn Injury	Tissue samples were harvested from healthy volunteers and participants who sustained burns. CACs were isolated and counted under fluorescence microscopy.	73 hours to 6 weeks post-operative